ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Childhood Cancer Survivors Do Not Have an Increased Risk Of Passing On Birth Defects

December 30, 2011

Virus Working Group Suggests 14 Projects As Suitable For New Contract Proposals

March 1, 1974

Broder Not Satisfied With Mortality STATS On Three Major Cancers

September 20, 1991

ONS Scientific Program Grows

June 20, 1980

Natcher Subcommittee Open Door To justification for Increasing Cancer Program 1982 Appropriation

April 3, 1981

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000